304 filings
Page 9 of 16
6-K
3lddyltu0vh3
9 Aug 16
GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress
12:00am
6-K
g96 bhl44q0yn
18 Jul 16
Current report (foreign)
12:00am
6-K
8ob0hvr9
14 Jul 16
Current report (foreign)
12:00am
424B5
y5gj0 b8i5
14 Jul 16
Prospectus supplement for primary offering
12:00am
FWP
gnv7gmnpz01sox go
13 Jul 16
Free writing prospectus
12:00am
424B5
rd9uj
12 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
drn66jo9svul2p
12 Jul 16
Current report (foreign)
12:00am
6-K
ppc1n4v4sjo6elf k0mh
27 Jun 16
GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
apudva
21 Jun 16
Current report (foreign)
12:00am
CT ORDER
npkwowjbae
16 Jun 16
Confidential treatment order
12:00am
6-K
2xe4 84ud
13 May 16
Current report (foreign)
12:00am
6-K
u7cg27qrp1ck
5 May 16
GW Pharmaceuticals plc Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
12:00am
6-K
878yrp
25 Apr 16
GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for the Treatment of Tuberous Sclerosis Complex
12:00am
6-K
e9mqzypwo9c3iq4yyhs9
11 Apr 16
Current report (foreign)
12:00am
6-K
6372hl
1 Apr 16
Current report (foreign)
12:00am
6-K
ssb2ysebo44 qz
14 Mar 16
Current report (foreign)
12:00am
6-K
tv0 83gbtm7mp
19 Feb 16
Current report (foreign)
12:00am
SC 13G/A
nv7tflkc8zpja40u
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
10xtk16 pidn
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
87dvdns
12 Feb 16
GW Pharmaceuticals PLC
12:00am